Jane Street’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Jane Street’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,200	Closed	-$481K	–	11118
2025 Q2	$481K	Buy	+17,200	New	+$461K	﹤0.01%	6992
2023 Q2	–	Sell	-40,200	Closed	-$1.55M	–	9001
2023 Q1	$1.55M	Buy	+40,200	New	+$1.65M	﹤0.01%	4248
2022 Q3	–	Sell	-5,100	Closed	-$285K	–	9955
2022 Q2	$285K	Sell	5,100 -1,600	-24%	-$94.9K	﹤0.01%	7685
2022 Q1	$416K	Buy	+6,700	New	+$410K	﹤0.01%	7819
2021 Q3	–	Sell	-7,000	Closed	-$482K	–	10216
2021 Q2	$482K	Sell	7,000 -5,400	-44%	-$412K	﹤0.01%	7311
2021 Q1	$956K	Sell	12,400 -15,200	-55%	-$1.4M	﹤0.01%	5537
2020 Q4	$2.73M	Sell	27,600 -13,400	-33%	-$1.64M	﹤0.01%	2948
2020 Q3	$5.82M	Sell	41,000 -187,400	-82%	-$31.2M	﹤0.01%	1702
2020 Q2	$45.1M	Buy	+228,400	New	+$47.3M	0.03%	396

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's LKFT Position: Q1 2026 in Review

Jane Street opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 13,607 shares worth $408K. The stake represents ﹤0.01% of the portfolio and ranks #8514 among its holdings. This is a return to the name: Jane Street previously reported a position in LKFT as recently as Q3 2025.

Jane Street first reported a position in LKFT in Q3 2015 and has held it in 28 quarters since. The position peaked at $20.8M in Q3 2018. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Jane Street held 13,607 shares of Lakefront Biotherapeutics American Depositary Shares worth $408K as of Q1 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Jane Street position in Q1 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8514 holding.
Jane Street first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 28 quarters since.
Jane Street's Lakefront Biotherapeutics American Depositary Shares position peaked at $20.8M in Q3 2018.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.